Notícias GlycoMimetics Inc - GLYC | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
GlycoMimetics Inc (GLYC)
GlycoMimetics Inc (GLYC) Notícias

GlycoMimetics Inc (GLYC)

0,242

0,0255

(11,78%)

Fechado 24 Dezembro 6:00PM

Atrasado por 15 minutos

0,2382

-0,0038

(-1,57%)

Após o horário de negociação: 6:56PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma

GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Well Far Fin 29

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições